Upside – $LPCN +40% (Health Canada approves TLANDO for testosterone replacement therapy) – $APUS +9.4% (extends a high-volume rally tied to the BlockAssure agreement to build and operate the AssureChain insurance network) – $PENG +4.3% (Q4 beat and FY27 sales and EPS outlook topped prior guidance and Street expectations on accelerating AI-infrastructure demand) – CNQ …
Read in context ›ASML Holding Stock (ASML)
Track ASML Holding stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
ASML
ASML Holding
technology
At close
$1,780.34
▲ +10.55 (+0.60%)
Oct 9, 4:00 PM ET
After-hours
$1,780.00
▼ -0.34 (-0.02%)
Oct 9, 7:59 PM ET
Market Cap
$685.47B
P/E Ratio
58.1x
1Y Return
+82.58%
EPS (TTM)
$32.15
Read the latest TheStreet Pro articles mentioning ASML Holding, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
77 articlesDaily Diary Mentions
4 mentionsUpside, Downside Movers in the Morning 'Subject to Macro Uncertainties' ASML Holding ASML with a miss on bookings — will put a pall over AI equities today.
Read in context ›Taiwan Semi's Call Speaks to AI Demand, Specialty Tech From Taiwan Semi’s TSM earnings call: “As the strong structural AI-related demand continues, we continue to invest to support our customers' growth. We now expect our 2024 CapEx to be slightly higher than $30 billion U.S…
Read in context ›Why the Drop? The proximate cause of the market's decline was that ASML pre-released weak order numbers a few minutes ago. The stock, which is -$115, was touted confidentally on FIN TV yesterday.
Read in context ›